Randall J Hogan
CIK 1189049 · Chairman & Chief Exec. Officer · last filed 2026-05-11
Randall J Hogan is a Chairman & Chief Exec. Officer who has filed 168 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider was granted $150.0K of KGS on May 11, 2026. Across all open-market trades the lifetime net is −$165.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $46.5M across reported positions. 24 SEC filings were submitted jointly with Medtronic plc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PNR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
9950 WOODLOCH FOREST DR. STE 1900
THE WOODLANDS, TX 77380
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KGS | Director | 30,541 | $46.86 | $1.43M | $376.9K | 5 | 2026-05-11 |
| MDT | Director | 86,003 | $96.54 | $8.30M | $0 | 23 | 2026-04-29 |
| NVT | Director | 242,334 | $125.98 | $30.53M | -$51.69M | 27 | 2024-05-20 |
| PNR | Chairman & Chief Exec. Officer | 93,897 | $66.26 | $6.22M | -$113.91M | 80 | 2018-04-19 |
| Covidien plc (COV) Delisted | Director | 17,871 | — | — | $12.9K | 31 | 2014-03-21 |
Recent Filings
168 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | KGS | Grant (A) | +2,135 | $150.0K | EDGAR |
| 2026-04-29 | MDT | Mixed | +1,904 | -$17.0K | EDGAR |
| 2026-03-16 | KGS | Buy (P) | +6,000 | $328.9K | EDGAR |
| 2025-04-30 | MDT | Mixed | +1,867 | $156.8K | EDGAR |
| 2025-04-24 | KGS | Grant (A) | +4,512 | $0 | EDGAR |
| 2024-05-20 | NVT | Tax (F) | −1,547 | -$123.8K | EDGAR |
| 2024-05-03 | MDT | Tax (F) | −192 | -$15.5K | EDGAR |
| 2024-05-01 | MDT | Grant (A) | +2,165 | $175.1K | EDGAR |
| 2024-05-01 | KGS | Grant (A) | +5,519 | $0 | EDGAR |
| 2024-02-12 | NVT | Mixed | — | -$7.66M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.